Eunjung Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Eunjung Kim has a total of 182 co-authors. Here are the top co-authors by number of shared publications:
- Yong-Min Huh
College of Medicine, Yonsei University, Seoul, Republic of Korea
24 shared publications - Seungjoo Haam
Department of Chemical and Biomolecular Engineering, Yonsei University, Seoul 03722, Republic of Korea
22 shared publications - Jin-Suck Suh
Department of Radiology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
20 shared publications - Eun-Kyung Lim
Bionanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Republic of Korea
18 shared publications - Jaemoon Yang
Department of Radiology, Yonsei University College of Medicine, Seoul, Republic of Korea
13 shared publications Jihye Choi
Department of Chemical and Biomolecular Engineering College of Engineering, Yonsei University Seoul 120‐749 Republic of Korea
9 shared publications
Latest Publications
- 24 September 2026
- Published by American Chemical Society (ACS) in ACS Sensors
Machine Learning-Assisted Multiplex Profiling of Plasma-Derived Exosomal miRNAs for Alzheimer's Disease Classification
Accurate diagnosis of Alzheimer's disease (AD) remains challenging due to its multifactorial nature and the limitations of current diagnostic methods. Exosome-derived microRNAs (miRNAs) have emerged as promising minimally invasive biomarkers, owing to their stability in peripheral biofluids and their ability to reflect molecular alterations associated with neurodegeneration. In this work, we report an ORCA–Cas assay that integrates a one-pot ligation/rolling circle amplification step with a subsequent CRISPR/Cas12a detection step for the sensitive and specific detection of AD-associated exosomal miRNAs in plasma samples. Four candidate miRNAs (miR-16-5p, miR-23a-5p, miR-574-5p, and miR-361-5p) were evaluated in plasma-derived exosomes from AD patients and healthy controls using both RT–qPCR and ORCA–Cas platforms. In an independent cohort (n = 27 per group), individual miRNAs exhibited modest discriminative performance, highlighting the need for multivariate integration. A random forest model was subsequently employed to integrate signals from the four-miRNA panel, achieving an area under the curve (AUC) of 0.877 with RT–qPCR data and an AUC of 0.923 with ORCA–Cas-derived data. These results demonstrate that combining amplification-assisted CRISPR-based miRNA detection with multivariate modeling improves the diagnostic utility of plasma-derived exosomal miRNA profiles. The ORCA–Cas assay provides a simple, multiplex-capable, and sensitive platform that supports a multi-marker profiling strategy for plasma-based AD molecular profiling and classification.
- 24 September 2026
- Published by American Chemical Society (ACS) in ACS Sensors
Machine Learning-Assisted Multiplex Profiling of Plasma-Derived Exosomal miRNAs for Alzheimer's Disease Classification
Accurate diagnosis of Alzheimer's disease (AD) remains challenging due to its multifactorial nature and the limitations of current diagnostic methods. Exosome-derived microRNAs (miRNAs) have emerged as promising minimally invasive biomarkers, owing to their stability in peripheral biofluids and their ability to reflect molecular alterations associated with neurodegeneration. In this work, we report an ORCA–Cas assay that integrates a one-pot ligation/rolling circle amplification step with a subsequent CRISPR/Cas12a detection step for the sensitive and specific detection of AD-associated exosomal miRNAs in plasma samples. Four candidate miRNAs (miR-16-5p, miR-23a-5p, miR-574-5p, and miR-361-5p) were evaluated in plasma-derived exosomes from AD patients and healthy controls using both RT–qPCR and ORCA–Cas platforms. In an independent cohort (n = 27 per group), individual miRNAs exhibited modest discriminative performance, highlighting the need for multivariate integration. A random forest model was subsequently employed to integrate signals from the four-miRNA panel, achieving an area under the curve (AUC) of 0.877 with RT–qPCR data and an AUC of 0.923 with ORCA–Cas-derived data. These results demonstrate that combining amplification-assisted CRISPR-based miRNA detection with multivariate modeling improves the diagnostic utility of plasma-derived exosomal miRNA profiles. The ORCA–Cas assay provides a simple, multiplex-capable, and sensitive platform that supports a multi-marker profiling strategy for plasma-based AD molecular profiling and classification.
- Open Access
- 3 July 2026
- Published by Wiley in Advanced Science
- Vol. 13 (54) , e76389
EpCAM + Extracellular Vesicle PD‐L1 Dynamics as a Predictive Biomarker of Immune Checkpoint Blockade Response
Programmed death‐ligand 1 (PD‐L1) blockade improves outcomes in patients with various malignancies; however, biomarkers for monitoring treatment responses are lacking. This study presents a surface‐enhanced Raman scattering (SERS)‐based platform for the ultrasensitive detection of PD‐L1 on circulating epithelial cell adhesion molecule‐positive (EpCAM + ) extracellular vesicles (EVs). The platform is validated using interferon‐gamma‐treated epithelial tumor cell line‐derived EVs. The platform is further applied to paired pre‐ and post‐treatment plasma samples from patients with non‐small‐cell lung cancer ( n = 140) and head and neck squamous cell carcinoma ( n = 73) receiving anti‐PD‐(L)1 immunotherapy. Dynamic changes in PD‐L1 expression on EV are shown to correlate with clinical outcomes. A post‐treatment decrease in PD‐L1 expression on EpCAM + EVs (EpCAM + EV PD‐L1) is associated with improved 5‐year progression‐free and overall survival. These results establish EpCAM + EV PD‐L1 as a dynamic, non‐invasive biomarker for monitoring immunotherapy responses and demonstrate the utility of SERS‐based profiling in predicting long‐term responses to immune checkpoint blockade.
- 3 July 2026
- Published by Wiley in Advanced Science
- Vol. 13 (54) , e76389
Open AccessEpCAM + Extracellular Vesicle PD‐L1 Dynamics as a Predictive Biomarker of Immune Checkpoint Blockade Response
Programmed death‐ligand 1 (PD‐L1) blockade improves outcomes in patients with various malignancies; however, biomarkers for monitoring treatment responses are lacking. This study presents a surface‐enhanced Raman scattering (SERS)‐based platform for the ultrasensitive detection of PD‐L1 on circulating epithelial cell adhesion molecule‐positive (EpCAM + ) extracellular vesicles (EVs). The platform is validated using interferon‐gamma‐treated epithelial tumor cell line‐derived EVs. The platform is further applied to paired pre‐ and post‐treatment plasma samples from patients with non‐small‐cell lung cancer ( n = 140) and head and neck squamous cell carcinoma ( n = 73) receiving anti‐PD‐(L)1 immunotherapy. Dynamic changes in PD‐L1 expression on EV are shown to correlate with clinical outcomes. A post‐treatment decrease in PD‐L1 expression on EpCAM + EVs (EpCAM + EV PD‐L1) is associated with improved 5‐year progression‐free and overall survival. These results establish EpCAM + EV PD‐L1 as a dynamic, non‐invasive biomarker for monitoring immunotherapy responses and demonstrate the utility of SERS‐based profiling in predicting long‐term responses to immune checkpoint blockade.
- 4 September 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (37) , 21345-21378
Rolling circle amplification for next-generation molecular diagnostics, genome analysis, and spatial transcriptome profiling
Rolling circle amplification (RCA) has emerged as a highly versatile and robust isothermal amplification technology, offering exceptional sensitivity, specificity, and scalability for next-generation molecular diagnostics and multi-omics research. Its ability to generate long, repetitive DNA sequences with high fidelity has made it a pivotal tool in disease diagnostics, genomic analysis, and spatial transcriptome profiling. Recent advancements have expanded RCA into various formats, including solution-phase, solid-phase, hydrogel-based, and digital RCA, enhancing its analytical performance and adaptability across diverse biological applications. The integration of RCA with CRISPR-based detection, biosensors, and nanoparticle-assisted signal amplification has significantly improved its diagnostic potential, enabling ultrasensitive detection of nucleic acids, proteins, extracellular vesicles, and single cells. In addition to diagnostics, RCA has profoundly impacted genomic research, particularly in extrachromosomal circular DNA sequencing, offering insights into genome instability and cancer evolution. In spatial transcriptomics, RCA-based in situ RNA sequencing and hybridization have enabled high-resolution gene expression mapping in tissue architecture, providing invaluable insights into cellular heterogeneity and disease microenvironments. This review comprehensively explores the fundamental principles, design modifications, and advanced signal amplification strategies of RCA, with a focus on its applications in molecular diagnostics, genome analysis, and spatial transcriptome profiling. Additionally, it addresses key challenges, including reaction specificity, automation, and cost-effectiveness, and discusses future directions for integrating RCA into high-throughput molecular diagnostics, biomarker discovery, and single-cell and spatial multi-omics platforms. Through continuous innovation, RCA is poised to play a transformative role in precision medicine, next-generation sequencing, and biomedical research.
- 4 September 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (37) , 21345-21378
Rolling circle amplification for next-generation molecular diagnostics, genome analysis, and spatial transcriptome profiling
Rolling circle amplification (RCA) has emerged as a highly versatile and robust isothermal amplification technology, offering exceptional sensitivity, specificity, and scalability for next-generation molecular diagnostics and multi-omics research. Its ability to generate long, repetitive DNA sequences with high fidelity has made it a pivotal tool in disease diagnostics, genomic analysis, and spatial transcriptome profiling. Recent advancements have expanded RCA into various formats, including solution-phase, solid-phase, hydrogel-based, and digital RCA, enhancing its analytical performance and adaptability across diverse biological applications. The integration of RCA with CRISPR-based detection, biosensors, and nanoparticle-assisted signal amplification has significantly improved its diagnostic potential, enabling ultrasensitive detection of nucleic acids, proteins, extracellular vesicles, and single cells. In addition to diagnostics, RCA has profoundly impacted genomic research, particularly in extrachromosomal circular DNA sequencing, offering insights into genome instability and cancer evolution. In spatial transcriptomics, RCA-based in situ RNA sequencing and hybridization have enabled high-resolution gene expression mapping in tissue architecture, providing invaluable insights into cellular heterogeneity and disease microenvironments. This review comprehensively explores the fundamental principles, design modifications, and advanced signal amplification strategies of RCA, with a focus on its applications in molecular diagnostics, genome analysis, and spatial transcriptome profiling. Additionally, it addresses key challenges, including reaction specificity, automation, and cost-effectiveness, and discusses future directions for integrating RCA into high-throughput molecular diagnostics, biomarker discovery, and single-cell and spatial multi-omics platforms. Through continuous innovation, RCA is poised to play a transformative role in precision medicine, next-generation sequencing, and biomedical research.
- Open Access
- 2 July 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (6) , e2500485
Membrane Fusion‐Inspired Nanomaterials: Emerging Strategies for Infectious Disease and Cancer Diagnostics
Membrane fusion, a foundational process in biological systems, has inspired the development of nanomaterials with transformative potential in biomedical applications, particularly in the diagnosis of infectious diseases and cancer. By emulating nature's intricate fusion mechanisms, these biomimetic nanomaterials offer unparalleled sensitivity, specificity, and versatility for detecting disease‐related biomarkers. Recent advancements have focused on engineering lipid nanoparticles that mimic viruses or exosomes, incorporating functionalization and signal amplification systems to enable targeted biomarker recognition and precise molecular interactions. Fusion‐inspired nanomaterials have emerged as powerful tools for rapid viral detection, exosome‐based liquid biopsies, and high‐throughput disease monitoring. Moreover, the incorporation of external stimuli—such as pH, ions, enzymes, and light—further enhances the spatiotemporal control of fusion events, paving the way for highly selective and responsive diagnostic tools. Despite remarkable progress, critical challenges remain in optimizing the stability, scalability, and precise control of these nanomaterials for clinical translation. This review provides a comprehensive overview of the principles underlying membrane fusion‐inspired nanomaterials, highlighting recent advancements, key challenges, and future directions in the field. As the field continues to evolve, these bioinspired systems hold immense promise for advancing next‐generation diagnostics and personalized medicine, offering a way for more accurate, efficient, and accessible healthcare solutions.
- 2 July 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (6) , e2500485
Open AccessMembrane Fusion‐Inspired Nanomaterials: Emerging Strategies for Infectious Disease and Cancer Diagnostics
Membrane fusion, a foundational process in biological systems, has inspired the development of nanomaterials with transformative potential in biomedical applications, particularly in the diagnosis of infectious diseases and cancer. By emulating nature's intricate fusion mechanisms, these biomimetic nanomaterials offer unparalleled sensitivity, specificity, and versatility for detecting disease‐related biomarkers. Recent advancements have focused on engineering lipid nanoparticles that mimic viruses or exosomes, incorporating functionalization and signal amplification systems to enable targeted biomarker recognition and precise molecular interactions. Fusion‐inspired nanomaterials have emerged as powerful tools for rapid viral detection, exosome‐based liquid biopsies, and high‐throughput disease monitoring. Moreover, the incorporation of external stimuli—such as pH, ions, enzymes, and light—further enhances the spatiotemporal control of fusion events, paving the way for highly selective and responsive diagnostic tools. Despite remarkable progress, critical challenges remain in optimizing the stability, scalability, and precise control of these nanomaterials for clinical translation. This review provides a comprehensive overview of the principles underlying membrane fusion‐inspired nanomaterials, highlighting recent advancements, key challenges, and future directions in the field. As the field continues to evolve, these bioinspired systems hold immense promise for advancing next‐generation diagnostics and personalized medicine, offering a way for more accurate, efficient, and accessible healthcare solutions.
- Open Access
- 8 November 2024
- Published by American Chemical Society (ACS) in ACS Measurement Science Au
- Vol. 4 (6) , 737-750
Design and Optimization of Isothermal Gene Amplification for Generation of High-Gain Oligonucleotide Products by MicroRNAs
Thermal cycling-based quantitative polymerase chain reaction (qPCR) represents the gold standard method for accurate and sensitive nucleic acid quantification in laboratory settings. However, its reliance on costly thermal cyclers limits the implementation of this technique for rapid point-of-care (POC) diagnostics. To address this, isothermal amplification techniques such as rolling circle amplification (RCA) have been developed, offering a simpler alternative that can operate without the need for sophisticated instrumentation. This study focuses on the development and optimization of toehold-mediated RCA (TRCA), which employs a conformationally switchable dumbbell DNA template for the sensitive and selective detection of cancer-associated miRNAs, specifically miR-21. In addition, we developed variants of hyperbranched TRCA (HTRCA), nicking-assisted TRCA (NTRCA), and hyperbranched NTRCA (HNTRCA) to facilitate exponential amplification by enhancing TRCA through the sequential incorporation of reverse primer (Pr) and nicking endonuclease (nE). By conducting a systematic kinetic analysis of the initial rate and end point signals for varying concentrations of key reaction components, we could identify optimal conditions that markedly enhanced the sensitivity and specificity of the TRCA variants. In particular, HNTRCA, which exploits the synergistic effect of Pr and nE, demonstrated an approximately 3000-fold improvement in the detection limit (260 fM) and a wider dynamic range of more than 4 log orders of magnitude compared to TRCA, thereby evidencing its superior performance. Also, we established a mechanistic model for TRCA that includes the roles of Pr and nE in different amplification processes. Model parameters were fitted to the experimental data, and additional simulations were conducted to compare the four amplification methods. Further tests with real biological samples revealed that this technique showed a good correlation with qPCR in quantifying miR-21 expression in various cell lines (0.9510 of Pearson's r), confirming its potential as a robust and rapid tool for nucleic acid detection. Therefore, the simplicity, high sensitivity, and potential for integration with POC diagnostic platforms make the HNTRCA system suitable for field deployment in resource-limited environments.
- 8 November 2024
- Published by American Chemical Society (ACS) in ACS Measurement Science Au
- Vol. 4 (6) , 737-750
Open AccessDesign and Optimization of Isothermal Gene Amplification for Generation of High-Gain Oligonucleotide Products by MicroRNAs
Thermal cycling-based quantitative polymerase chain reaction (qPCR) represents the gold standard method for accurate and sensitive nucleic acid quantification in laboratory settings. However, its reliance on costly thermal cyclers limits the implementation of this technique for rapid point-of-care (POC) diagnostics. To address this, isothermal amplification techniques such as rolling circle amplification (RCA) have been developed, offering a simpler alternative that can operate without the need for sophisticated instrumentation. This study focuses on the development and optimization of toehold-mediated RCA (TRCA), which employs a conformationally switchable dumbbell DNA template for the sensitive and selective detection of cancer-associated miRNAs, specifically miR-21. In addition, we developed variants of hyperbranched TRCA (HTRCA), nicking-assisted TRCA (NTRCA), and hyperbranched NTRCA (HNTRCA) to facilitate exponential amplification by enhancing TRCA through the sequential incorporation of reverse primer (Pr) and nicking endonuclease (nE). By conducting a systematic kinetic analysis of the initial rate and end point signals for varying concentrations of key reaction components, we could identify optimal conditions that markedly enhanced the sensitivity and specificity of the TRCA variants. In particular, HNTRCA, which exploits the synergistic effect of Pr and nE, demonstrated an approximately 3000-fold improvement in the detection limit (260 fM) and a wider dynamic range of more than 4 log orders of magnitude compared to TRCA, thereby evidencing its superior performance. Also, we established a mechanistic model for TRCA that includes the roles of Pr and nE in different amplification processes. Model parameters were fitted to the experimental data, and additional simulations were conducted to compare the four amplification methods. Further tests with real biological samples revealed that this technique showed a good correlation with qPCR in quantifying miR-21 expression in various cell lines (0.9510 of Pearson's r), confirming its potential as a robust and rapid tool for nucleic acid detection. Therefore, the simplicity, high sensitivity, and potential for integration with POC diagnostic platforms make the HNTRCA system suitable for field deployment in resource-limited environments.
- 9 May 2024
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 259, 116375
Dual structure-switching aptamer-mediated signal amplification cascade for SARS-CoV-2 detection
- 9 May 2024
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 259, 116375
Dual structure-switching aptamer-mediated signal amplification cascade for SARS-CoV-2 detection
- 29 April 2023
- Published by Wiley in Advanced Functional Materials
- Vol. 33 (31)
Membrane Rigidity‐Tunable Fusogenic Nanosensor for High Throughput Detection of Fusion‐Competent Influenza A Virus
The emergence of fatal viruses that pose continuous threats to global health has fueled the intense effort to develop direct, accurate, and high‐throughput virus detection platforms. Current diagnostic methods, including qPCR and rapid antigen tests, indicate how much of the virus is present, whether small fragments or whole viruses. However, these methods do not indicate the probability of the virus to be active, capable of interacting with host cells and initiating the infection cycle. Herein, a sialic acid‐presenting fusogenic liposome (sLipo–Chol) nanosensor with purposefully modulated membrane rigidity to rapidly detect the fusion‐competent influenza A virus (IAV) is developed. This nanosensor possesses virus‐specific features, including hemagglutinin (HA) binding and HA‐mediated membrane fusion. It is explored how the fusogenic capability of sLipo–Chol with different membrane rigidities impacts their sensing performance by integrating Förster resonance energy transfer (FRET) pairs into the bilayers. The addition of an intact virus led to instant FRET signal changes, thus enabling the direct detection of diverse IAV subtypes—even in avian fecal samples—within an hour at room temperature. Therefore, the sensing approach, with an understanding of the cellular pathogenesis of influenza viruses, will aid in developing bioinspired nanomaterials for evolution into nanosystems to detect infection‐competent viruses.
- 29 April 2023
- Published by Wiley in Advanced Functional Materials
- Vol. 33 (31)
Membrane Rigidity‐Tunable Fusogenic Nanosensor for High Throughput Detection of Fusion‐Competent Influenza A Virus
The emergence of fatal viruses that pose continuous threats to global health has fueled the intense effort to develop direct, accurate, and high‐throughput virus detection platforms. Current diagnostic methods, including qPCR and rapid antigen tests, indicate how much of the virus is present, whether small fragments or whole viruses. However, these methods do not indicate the probability of the virus to be active, capable of interacting with host cells and initiating the infection cycle. Herein, a sialic acid‐presenting fusogenic liposome (sLipo–Chol) nanosensor with purposefully modulated membrane rigidity to rapidly detect the fusion‐competent influenza A virus (IAV) is developed. This nanosensor possesses virus‐specific features, including hemagglutinin (HA) binding and HA‐mediated membrane fusion. It is explored how the fusogenic capability of sLipo–Chol with different membrane rigidities impacts their sensing performance by integrating Förster resonance energy transfer (FRET) pairs into the bilayers. The addition of an intact virus led to instant FRET signal changes, thus enabling the direct detection of diverse IAV subtypes—even in avian fecal samples—within an hour at room temperature. Therefore, the sensing approach, with an understanding of the cellular pathogenesis of influenza viruses, will aid in developing bioinspired nanomaterials for evolution into nanosystems to detect infection‐competent viruses.
Rapid Visible Detection of African Swine Fever Virus Using Hybridization Chain Reaction‐Sensitized Magnetic Nanoclusters and Affinity Chromatography
African swine fever virus (ASFV) is a severe and persistent threat to the global swine industry. As there are no vaccines against ASFV, there is an immense need to develop easy‐to‐use, cost‐effective, and rapid point‐of‐care (POC) diagnostic platforms to detect and prevent ASFV outbreaks. Here, a novel POC diagnostic system based on affinity column chromatography for the optical detection of ASFV is presented. This system employs an on‐particle hairpin chain reaction to sensitize magnetic nanoclusters with long DNA strands in a target‐selective manner, which is subsequently fed into a column chromatography device to produce quantitatively readable and colorimetric signals. The detection approach does not require expensive analytical apparatus or immobile instrumentation. The system can detect five genes constituting the ASFV whole genome with a detection limit of ≈19.8 pm in swine serum within 30 min at laboratory room temperature. With an additional pre‐amplification step using polymerase chain reaction (PCR), the assay is successfully applied to detect the presence of ASFV in 30 suspected swine samples with 100% sensitivity and specificity, similar to quantitative PCR. Thus, this simple, inexpensive, portable, robust, and customizable platform for the early detection of ASFV can facilitate the timely surveillance and implementation of control measures.
Rapid Visible Detection of African Swine Fever Virus Using Hybridization Chain Reaction‐Sensitized Magnetic Nanoclusters and Affinity Chromatography
African swine fever virus (ASFV) is a severe and persistent threat to the global swine industry. As there are no vaccines against ASFV, there is an immense need to develop easy‐to‐use, cost‐effective, and rapid point‐of‐care (POC) diagnostic platforms to detect and prevent ASFV outbreaks. Here, a novel POC diagnostic system based on affinity column chromatography for the optical detection of ASFV is presented. This system employs an on‐particle hairpin chain reaction to sensitize magnetic nanoclusters with long DNA strands in a target‐selective manner, which is subsequently fed into a column chromatography device to produce quantitatively readable and colorimetric signals. The detection approach does not require expensive analytical apparatus or immobile instrumentation. The system can detect five genes constituting the ASFV whole genome with a detection limit of ≈19.8 pm in swine serum within 30 min at laboratory room temperature. With an additional pre‐amplification step using polymerase chain reaction (PCR), the assay is successfully applied to detect the presence of ASFV in 30 suspected swine samples with 100% sensitivity and specificity, similar to quantitative PCR. Thus, this simple, inexpensive, portable, robust, and customizable platform for the early detection of ASFV can facilitate the timely surveillance and implementation of control measures.
- 5 December 2022
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 148 (2) , 316-327
A highly specific and flexible detection assay using collaborated actions of DNA-processing enzymes for identifying multiple gene expression signatures in breast cancer
Most nucleic acid biosensors employ nucleic acid-processing enzymes to bind, degrade, splice, synthesize, and modify nucleic acids. Utilizing their unique substrate preference, binding mode, and catalytic activity is of great importance in designing nucleic acid biosensors. Combination with DNA-processing enzymes enables them to transform into a new generation of molecular diagnostics tools with enhanced selectivity and sensitivity and reduced reaction time. Here, we report an isothermal amplification strategy by coemploying a structure-specific endonuclease (flap endonuclease 1, FEN1) and a strand-displacing DNA polymerase (Bst DNA polymerase) to detect long RNA targets. This approach couples the FEN1-driven invasive cleavage reaction with toehold-mediated rolling circle amplification (iFEN–tRCA), enabling the highly selective and rapid detection of long RNA targets and offering a detection limit below 10 pM within 1 h. We used two targets, such as human epidermal growth factor receptor 2 (HER2, encoded by ERBB2) and dopamine- and cyclic AMP-regulated phosphoprotein (DARPP, encoded by PPP1R1B), associated with prognosis or response to anticancer therapy. We demonstrated the feasibility and quantitative capability of the iFEN–tRCA assay by assessing the expression of two RNA transcripts (ERBB2 and PPP1R1B) with total RNA extracts purified from human breast cancer cells. Therefore, we envision that the developed assay will provide a suitable prognostic and diagnostic tool for identifying appropriate patients for HER2-targeted therapy and predicting the clinical outcome and occurrence of metastasis relapse in breast cancer.
- 5 December 2022
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 148 (2) , 316-327
A highly specific and flexible detection assay using collaborated actions of DNA-processing enzymes for identifying multiple gene expression signatures in breast cancer
Most nucleic acid biosensors employ nucleic acid-processing enzymes to bind, degrade, splice, synthesize, and modify nucleic acids. Utilizing their unique substrate preference, binding mode, and catalytic activity is of great importance in designing nucleic acid biosensors. Combination with DNA-processing enzymes enables them to transform into a new generation of molecular diagnostics tools with enhanced selectivity and sensitivity and reduced reaction time. Here, we report an isothermal amplification strategy by coemploying a structure-specific endonuclease (flap endonuclease 1, FEN1) and a strand-displacing DNA polymerase (Bst DNA polymerase) to detect long RNA targets. This approach couples the FEN1-driven invasive cleavage reaction with toehold-mediated rolling circle amplification (iFEN–tRCA), enabling the highly selective and rapid detection of long RNA targets and offering a detection limit below 10 pM within 1 h. We used two targets, such as human epidermal growth factor receptor 2 (HER2, encoded by ERBB2) and dopamine- and cyclic AMP-regulated phosphoprotein (DARPP, encoded by PPP1R1B), associated with prognosis or response to anticancer therapy. We demonstrated the feasibility and quantitative capability of the iFEN–tRCA assay by assessing the expression of two RNA transcripts (ERBB2 and PPP1R1B) with total RNA extracts purified from human breast cancer cells. Therefore, we envision that the developed assay will provide a suitable prognostic and diagnostic tool for identifying appropriate patients for HER2-targeted therapy and predicting the clinical outcome and occurrence of metastasis relapse in breast cancer.